About / Media Center
Trinity Press Releases
Filter by Type:
Survey Finds Pharma Execs Uncertain About how COVID-19 Will Affect the Volume of Business Development Efforts
Waltham, MA, June 4, 2020 — Trinity Life Sciences, a leader in global life sciences solutions, finds that New Product Planning (NPP) pharmaceutical executives are uncertain about how COVID-19 will affect the volume of business development efforts. According to the new...
COVID-19-Related Discussions Dominate Trinity’s TGaS Spring Summit
Drug launches during COVID-19 was a significant topic during the Summit. A recent TGaS benchmarking survey showed that 89 percent of companies have had an impact to their pre-launch activities due to COVID-19, with almost half of these companies reporting high...
New Report Cautions Pharma that a Big Budget Does Not Always Equate to a High-Performing Launch
Waltham, MA, May 19, 2020 — Trinity Life Sciences, a leader in global life sciences solutions, is sharing findings from its latest TGaS Landscape report entitled, “Launch Excellence Advisory Study.” The report is based on interviews of 30 biopharmaceutical company Chief...
Trinity Life Sciences Assesses Pharma/Biotech Commercial Performance Trends
Waltham, Mass., May 6, 2020 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the availability of its 2019 Trinity Drug Index, a commercial analysis of 26 unique therapeutic agents approved in 2016. The Index shows several...
New Assessment Identifies the High-Risk Functions Within Pharma that are Least Prepared for Challenges Ahead
Waltham, MA, April 28, 2020 — Trinity Life Sciences, a leader in global life sciences solutions, announced today the availability of a new TGaS benchmarking assessment that identifies the high-risk functions within pharma that are least prepared for challenges generated by...
Forty Percent of Healthcare Providers Across a Wide Range of Specialties are Using More Telemedicine Than Before COVID-19
Waltham, MA, April 22, 2020 — Trinity Life Sciences, a leader in global life sciences solutions, announced today the availability of a new brief regarding the impact of COVID-19 on telehealth. The brief, based on a survey of 561 healthcare providers...
Trinity Life Sciences Names Peter Hoenigsberg to its Board of Directors
Hoenigsberg’s CEO and private equity experience brings a valuable level of business knowledge and perspective to the Board.
U.S. Physicians Still Willing to Participate in Healthcare Market Research During Coronavirus Pandemic
New brief finds that physicians in private practices or community settings have an increased availability to participate in research, driven partially by a decrease in on-site patient volume.
Trinity Life Sciences Offers Digital Approach to Understanding the Patient Journey
The full-service solution uses multiple online tools to uncover deep insights into patients’ clinical and emotional experiences.
Trinity Life Sciences Monitors Coronavirus Impact on Biopharm Operations
Some of the immediate results show that 100 percent of biopharmaceutical companies participating in the survey say they have travel restrictions in place.
Trinity Life Sciences Introduces the First and Only End-to-End Market Access Solution for Biopharma
New offering includes expertise on market access, pricing and contracting.
Trinity Life Sciences Continues to See Inflective Growth in Health Economics and Outcomes Research Practice
HEOR, one of the fastest-growing functions in the pharmaceutical industry, provides value-based insight to pharmaceutical companies and assists healthcare payers in determining if treatments are effective in the populations they serve.